TLSI
TriSalus Life Sciences Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Operating | |||||
| Operating Cash Flow | — | — | — | — | — |
| Net Income | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — |
| Changes in WC | — | — | — | — | — |
| Investing | |||||
| Capital Expenditures | 918,000 | 345,000 | 588,000 | 655,000 | — |
| Acquisitions | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — |
| Financing | |||||
| Debt Repayment | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — |
| Buybacks | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Summary | |||||
| Free Cash Flow | -18.9M | -41.2M | -51.2M | -33.0M | — |
| Net Change in Cash | — | — | — | — | — |